Skip to main content

Hoylecohen, LLC

SEC CIK
0001559077
Latest filing
Jul 19, 2024

ARWR holding history

Arrowhead Pharmaceuticals, Inc. in every 13F filed by Hoylecohen, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ARWR overviewAll 13F holders of ARWRFull Q2 2024 holdings

Shares (Q2 2024)
15,550
Value
$404.1K
% of portfolio
<0.1%
Quarters held
14
Since Q1 2021
Holdings of ARWR by Hoylecohen, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202415,550$404.1K<0.1%00.0%UnchangedHolders
Q1 202415,550$444.7K<0.1%00.0%UnchangedHolders
Q4 202315,550$475.8K<0.1%00.0%UnchangedHolders
Q3 202315,550$417.8K<0.1%00.0%UnchangedHolders
Q2 202315,550$554.5K<0.1%00.0%UnchangedHolders
Q1 202315,550$395.0K<0.1%00.0%UnchangedHolders
Q4 202215,550$630.7K0.1%00.0%UnchangedHolders
Q3 202215,550$514.0K0.1%00.0%UnchangedHolders
Q2 202215,550$548.0K0.1%00.0%UnchangedHolders
Q1 202215,550$715.0K0.1%00.0%UnchangedHolders
Q4 202115,550$1.03M0.1%00.0%UnchangedHolders
Q3 202115,550$971.0K0.1%00.0%UnchangedHolders
Q2 202115,550$1.29M0.1%00.0%UnchangedHolders
Q1 202115,550$1.03M0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.